Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis

OBJECTIVES: Patients with rheumatoid arthritis are prone to developing diabetes, which may lead to various sequelae and even cardiovascular diseases, the most common cause of death in such patients. Previous research has shown that some rheumatoid arthritis treatments may help prevent the developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yu-Jih, Chen, Hui-Ming, Chan, Tien-Ming, Cheng, Tien-Tsai, Yu, Shan-Fu, Chen, Jia-Feng, Lin, Chun-Yu, Hsu, Chung-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357650/
https://www.ncbi.nlm.nih.gov/pubmed/37460274
http://dx.doi.org/10.1136/rmdopen-2023-003045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357650/
https://www.ncbi.nlm.nih.gov/pubmed/37460274
http://dx.doi.org/10.1136/rmdopen-2023-003045

Ejemplares similares